Company intelligence / Profile preview
Beijing Tide Pharmaceutical Co., Ltd.
Beijing, Beijing, Chinaen.tidepharm.com ↗
- Ownership
- Private
- Employees
- ~180
- Development stage
- Other
01
Overview
The company has multiple approved products including Flurbiprofen Axetil Injection and Alprostadil. Their innovative drug TDI01 for COVID-19 was approved for clinical trials in September 2022 and has completed Phase I trials in the US with good safety results. The company also has products in Phase 3 trials for diabetic peripheral neuropathic pain and osteoarthritis.
- Therapeutic areas
- PulmonologyOncologyRheumatologyGastroenterologyCardiovascularNeurologyInfectious Diseases
- Modalities
- Small moleculesBiologicsEnzymeAntibody fusion proteinsChemical drugsBiosimilar
- Industry
- Biotech
02
Drug pipeline
14 assets13 more assets in the full pipeline.
03
Partnerships
Mikasa Seiyaku Co., Ltd.American company for tricuspid valve repairJapanese pharmaceutical companies (OEM)
Beyond the preview
Go deeper on Beijing Tide Pharmaceutical Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Beijing Tide Pharmaceutical Co., Ltd..